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Abstract 
Aim: To investigate the influence of gold nanoparticle (GNP) geometry on the 
biochemical response of Calu-3 epithelial cells. 
 
Materials and Methods: Spherical, triangular and hexagonal GNPs were used. The 
GNP-cell interaction was assessed via atomic absorption spectroscopy (AAS) and 
transmission electron microscopy (TEM). The biochemical impact of GNPs was 
determined over 72hrs at [0.0001-1mg/mL]. 
 
Results: At 1mg/mL, hexagonal GNPs reduced Calu-3 viability below 60%, showed 
increased reactive oxygen species production and higher expression of pro-apoptotic 
markers. A cell mass burden of 1:2:12 as well as number of GNPs per cell (2:1:3) was 
observed for spherical:triangular:hexagonal GNPs.  
 
Conclusion:  
These findings do not suggest a direct shape-toxicity effect. However, do highlight the 
contribution of shape towards the GNP-cell interaction which impacts upon their 
intracellular number, mass and volume dose.  
 
 
 
 
Introduction 
Due to their plasmonic properties, gold nanoparticles (GNPs) have been proposed as 
advantageous nano-sized materials for use in the various diagnostic and therapeutic 
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applications, such as cell imaging, targeted drug delivery, thermal ablation, phototherapy [1-
7].. To date spherical GNPs have been proven as one of the most biocompatible NP 
models for biological-based applications [8-12]. Recently, it has been reported that 
the specific shape of GNPs can be exploited to advantageously tune these 
nanomaterials for any biomedical application of choice [8,13]. Examples of such 
alternatively shaped GNPs being produced include, amongst others, rods, triangles, 
hexagons, prisms, urchins, cubes and wires [11,14]. Triangular and hexagonal GNPs 
have been specifically reported as promising contrast agents for in vivo imaging 
applications in place of the commonly used spherical GNPs [8,13,15]. The reason for 
this is due to the shift of the optical resonance of these differently shaped GNPs to the 
near-infrared region of the spectrum, which allows for a greater potential to penetrate 
deeper inside tissues without photobleaching [5,13,16].  
 
Therefore, to envisage the use of these alternatively shaped GNPs within any potential 
medical applications their biocompatibility must be realised. In this regard increased 
attention has recently been focused towards their cellular interaction[17]. Although it 
is well known that specific physico-chemical characteristics (e.g. size, surface 
chemistry) of GNPs can indeed influence their cellular uptake and accumulation 
[10,18], the ability for shape to play a significant role in their interaction of GNPs 
with mammalian cells in vitro is not fully understood. Many studies have undertaken 
investigations into how differently shaped NPs may interact with, or be internalised 
by mammalian cells [19], yet in order to fully comprehend the potential of 
alternatively shaped GNPs for biomedical applications, their biochemical impact must 
also be considered [20]. However, understanding as to how the manipulation of GNP 
shape relates to their biocompatibility is equivocal [5,21,22].  
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The aim of the present study, therefore, was to assess the biological impact of three 
differently shaped GNPs (spherical, triangular and hexagonal) with identical surface 
chemistry (applied with a common mass dose), upon a representative airway epithelial 
barrier (Calu-3) in vitro cell system. It is important to note that a pulmonary epithelial 
cell-line was chosen, since GNPs are successfully being developed for both systemic 
and local applications, i.e. for lung tumor delivery via inhalation[23]. Further to this, 
due to the fragility of the respiratory epithelium this area is considered particularly 
sensitive towards (nano)particle-cell interactions [24]. It was hypothesized that the 
shape of the GNPs, particularly due to their external dimensions, would play a role in 
the resultant biological impact of the GNPs in vitro. It is also noteworthy that since an 
observed change in biological impact might be related to NP surface chemistry rather 
than geometry[25], all GNPs were controlled for their surface functionalised with a 
carboxylated polyethylene glycol chain (SH-PEG-COOH) [26]. Furthermore, to 
ensure identical composition, all GNPs were collectively synthesized together prior to 
subsequent shape separation via electrophoresis [1].  
 
 
 
MATERIALS AND METHODS 
Chemicals and reagents. All chemicals and reagents were purchased from Sigma-
Aldrich (Germany) unless otherwise stated. 
 
Preparation of pristine GNPs. GNPs were prepared via reduction of chloroauric 
acid (HAuCl4) using sodium thiosulfate as reducing agent as previously described in 
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the synthesis of triangular gold nanoprisms [8,13]. Although nanoprisms are the main 
product of this synthesis, a small proportion (10-15%) of spherical and hexagonal NPs 
can be obtained as a by-product. It is also important to note that due to the absence of 
any cationic detergent (e.g. CTAB – cetyltrimethylammonium bromide 
C16H33N(CH3)3Br), the synthesis method used represents a biocompatible alternative 
to using such cationic-based synthesis routes, and allows the surface of the GNPs to 
be readily functionalised with organic molecules.  
 
Prior to use, all glassware was washed with aqua regia for at least 1 hour and rinsed 
thoroughly with Milli-Q water. A typical synthesis required 10 mL of 2 mM 
chloroauric acid and 12 mL of 0.5 mM sodium thiosulfate (reducing agent). Within 
the initial 5 minutes of the reaction, the colour of the solution changed from yellow 
(gold salt) to brownish, indicating the formation of GNPs. The reaction was 
subsequently stirred at room temperature for an additional 12 minutes prior to a 
second addition (5 mL) of reducing solution (0.5 mM sodium thiosulfate) and 
incubated for a further 78 minutes until complete. The formation of GNPs was 
confirmed via UV-Vis spectroscopy (Perkin Elmer Lambda 900 UV/VIS/NIR 
Spectrometer, USA).at an absorbance of 0.3 at wavelengths of 528 nm, 900 nm and 
1100 nm respectively  GNPs were stable in Milli-Q water for up to 12 months when 
stored at room temperature [13]. 
 
Surface functionalisation of GNPs with PEG. To promote their colloidal stability, 
GNPs were functionalised with hetero-bifunctional (HS–C2H4–CONH–PEG–O–
C3H6–COOH (M.W. 5000 g/mol) (Rapp-Polymere, Tübingen, Germany) 
polyethylene glycol (PEG) chains as previously described [13]. Following surface 
6 
 
functionalisation, 10 mL of GNPs was supplemented with 1 mg of thiolated PEG, and 
the pH adjusted to 12. Samples were then incubated overnight at room temperature. 
Following the incubation period, the free hetero-bi-functional spacer (HS-PEG-
COOH) was removed by washing three times via centrifugation (11’200 rcf for 15 
minutes). HS–PEG–COOH functionalised GNPs were then subsequently re-
suspended in Milli-Q water and lyophilised at a concentrated solution of 20 mg/mL.  
 
Shape separation of GNPs. As previously reported, the high colloidal stability of the 
NPs enabled separation of the GNPs functionalised with HS–PEG–COOH according 
to their electrophoretic mobility (i.e. via electrophoresis) [13]. Briefly, an aqueous 
solution of 0.8% w/v Agarose gel was prepared and immersed in Tris-borate-EDTA 
(TBE) buffer. The gel of 7x7 cm and 1 cm thick was run on a horizontal 
electrophoresis system having an electrode spacing of 15 cm (Bio-Rad, Mini-Sub Cell 
GT System, USA). After electrophoresis at 200 V, the shape separated GNPs were 
identified by their distinct colour bands (i.e. pink: spherical GNPs, black: triangular 
GNPs or grey: hexagonal GNPs) present on the electrophoresis gel. It is important to 
note that a 10% fraction of the hexagonal GNPs were observed to be of a triangular 
geometry. The concentration of each shaped GNP was 10 mg/mL, as determined by 
inductively coupled plasma-mass spectrometry (ICP-MS) (Thermo Scientific, USA) 
[27]. The numbers of spherical, triangular and hexagonal GNPs per mL was 
determined to be 3.6±1.3 x10
14
, 8.3±3.5 x10
13
 and 3.5±0.3 x10
13
 respectively (Table 
1).  
 
GNP Physico-chemical characterisation. The key physico-chemical characteristics 
of each differently shaped GNP are detailed in table 1. Each GNP type was suspended 
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in Roswell Park Memorial Institute (RMPI) 1640 cell culture medium without any 
additional supplementation and analysed for their morphology, size and surface 
charge. To assess GNP morphology, a total of 10 l of GNP solution was pipetted 
onto a 300-mesh grid prior to evaluation by transmission electron microscopy (TEM) 
(Hitachi SU6600 instrument, Japan) (Figure 1). Additionally, TEM images were used 
to calculate the average dimensions of each GNP shape (n=200 GNPs counted)) 
(Table 1). To further assess the dimensions of each GNP, dynamic light scattering 
(DLS) was performed via a NanoZetasizer ZS analyser (Malvern Instruments, 
Worcestershire, UK). For size measurements, 100 g/mL GNPs in RPMI 1640 
medium were dispersed in DTS0012 cuvettes. The refractive index (RI) of 1.6 for 
GNPs was used [28]. Prior to analysis, viscosity measurements were performed on 
medium with the aid of a Viscometer SV-10 (A&D Instruments Ltd., UK) at 25 °C 
and the recorded values used for all DLS size estimations. The samples were 
equilibrated at 25 °C for three minutes prior to each measurement. Additionally, the 
surface charge (i.e. zeta potential) of each GNP was also measured in supplemented 
RPMI 1640 medium (as stated above) by a NanoZetasizer ZS analyser (Malvern 
Instruments, Worcestershire, UK)[29]. For zeta potential measurements, DTS1060C 
clear disposable zeta cells were used and the measurements were performed at 5 V. 
All characteristics were determined from three independent measurements (n=3) at a 
concentration of 0.1 mg/mL.  
 
Cell culture. The human adenocarcinoma airway epithelial cell-line (Calu-3) was 
purchased from LGC Promochem (Wesel, Germany). This specific cell type was used 
as a model cell-line to study pulmonary exposure to GNPs. Cells were cultured in 
complete culture medium composed of RPMI 1640 with L-Glutamine (Invitrogen, 
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Germany) supplemented with 10% (v/v) Foetal Bovine Serum (Sigma Aldrich, 
Germany) and 1% (v/v) 10000 U/ml Penicillin and 10000 U/ml Streptomycin 
(Invitrogen, Germany). Cells were maintained on flasks under standard culture 
conditions (5% CO2, 95% relative humidity and 37 °C), and sub-cultured every 72 
hours. Cell passage # 7-10 at a seed density of 2x10
4
/cm
2
 upon a seeding area of 0.8 
cm
2
 was used for all experimentation, unless otherwise stated. 
 
Estimation of internalised GNPs by Atomic Absorption Spectroscopy. Atomic 
Absorption Spectroscopy (AAS) was employed to quantify the total gold mass per 
dish using a SpectrAA200 (Varian, USA) atomic absorption spectrometer with direct 
comparison to a commercially purchased AAS gold standard (TraceCERT, Fluka) 
(Table 2). Cells were exposed, via the suspension method, to 1 mg/mL GNPs in 10 
mL medium (10 mg NPs) in a 10 cm diameter petri-dish. After 72 hours exposure at 
37 °C, 5% CO2, the cell culture medium was removed and attached cells were 
thoroughly washed with PBS. To further remove GNPs that were loosely associated 
to the cell membrane, cells were washed with PBS and subsequently detached by 
trypsinization. Following this, cells were washed five times with PBS via 
centrifugation (10 minutes at 1400 rpm). Cells were then counted using a Z2 Coulter 
counter (Beckman Coulter, USA) and subsequently air-dried for 24 hours at room 
temperature. Following the incubation period, samples were dispersed in 8 mL water 
and then sonicated for 30 minutes at 135 W and room temperature to ensure a uniform 
distribution of GNPs in the sample prior to AAS analysis [31]. The total mass of 
associated (either internalised or tightly bound to the cell surface) gold per sample 
was determined by three independent measurements (n=3) and presented as the 
average absorbance. In addition, the individual volume of single GNPs was observed 
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by TEM, allowing for the further estimation of the total number of GNPs per dish 
(Table 2).  
 
TEM. To determine the sub-cellular deposition of GNPs, conventional TEM was 
used. At a density of 5×10
5
, Calu-3 cells were seeded in a 30 mm
2
 polystyrene dish 
for 24 hours at 37 °C, 5% CO2. Please note that in accordance with the increased cell 
density, GNP concentration was also increased to serve the same NP per cell 
concentration. This was performed due to the inherent nature of TEM sample 
processing, in which cell number can be significantly reduced via the dehydration, 
washing and staining steps [30]. Cells were subsequently incubated with 0.1 mg/mL 
(3mL volume) GNPs for 72 hours. It is further important to consider that the 
concentration used here corresponds to that used for AAS. Following the exposure 
period, cells were washed with three times with PBS and then fixed in 2% 
paraformaldehyde/2.5% glutaraldehyde/0.15 M sodium phosphate at pH 7.4 
overnight. Following the fixation period, samples were prepared for TEM as 
previously described by Brandenberger et al.[3] Ultrastructural analysis and 
photomicroscopy was performed with an EM400 TEM (Philips, The Netherlands). At 
least five independent fields of view from three individual samples were captured in 
order to provide a representative qualitative understanding of the interaction between 
the different shaped GNPs and the Calu-3 cells.  
 
Biocompatibility tests  
WST-1 Assay. At a density of 1x10
4
 per well, cells were seeded (in a 6-well Petri-
dish). After exposure to GNPs at 0.0001 to 1 mg/mL for 10 days, cells (which were 
grown in colonies) were stained violet in colour with Carbol Fuchsin Solution (VWR 
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international, Ltd. England). Viable cells were subsequently normalised by plating 
efficiency controls [31]. Analysis was performed in triplicate from three independent 
experiments (n=3). Data is presented as a percentage of cell viability compared to the 
negative control. 
 
Assessment of Plasma Membrane Damage. The impact of GNP shape upon 
eliciting cell membrane damage was determined by the release of lactate 
dehydrogenase (LDH) from exposed cells, as quantified in cell culture supernatants 
by a CytoTox 96 cytotoxicity assay (Promega, Germany). At 1x10
4
, Calu-3 cells were 
exposed to each differently shaped GNP at different concentrations for 72 hours. 
Triton 1% was used as positive control. Briefly, following manufacturer’s guidelines, 
50 μl/well supernatant was collected, and then incubated with an equivalent volume 
of substrate solution for 30 minutes at room temperature in the dark. Following the 
incubation period, 50 μl/well of stop solution was added. Each sample was filled by 
an Amicon Ultra-0.5 centrifugal filter device (Millipore, Germany) and spun at 6000 
rpm for two minutes to remove the particles in suspension. The absorbance value of 
each filtrated sample was determined at a wavelength of 490 nm and 630 nm as 
reference via spectrophotometry. Since spherical GNPs have a spectrum of 528 nm, 
the according concentration of spherical GNPs was used as a colorimeric control to 
remove the background absorbance. The triangular and hexagonal GNPs have a 
spectrum over 900nm and thus do not overlap with the wavelengths used within the 
LDH assay. Analysis was performed in triplicate from three independent experiments 
(n=3). Data is presented as the percentage LDH release compared to the positive 
control (0.2% Triton X100).  
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Cathepsin-B expression. Cathepsin-B expression, was measured by a Cathepsin B 
expression Assay Kit (PK-CA577-K140, PromoKine, Germany) according to 
manufacturer’s instructions. Briefly, Calu-3 cells were seeded at 1x104 and then 
exposed to each shape of GNPs at a concentration of 0.01, 0.1 and 1 mg/mL in a 96-
well culture plate for 72 hours. Cells were then lysed in 50 μl of chilled Cathepsin-B 
Cell Lysis buffer at 4°C for 10 minutes. Subsequently, 50 μl clear cell lysate was 
transferred to a 96-well plate and reacted with 50 μl of Cathepsin B reaction buffer 
and 2 μl of the 10 mM Cathepsin B obtained from the kit (substrate Ac-RR-AFC (200 
μM as final concentration)) and incubated for one hour at 37 °C. Cathepsin B 
expression was then quantified by samples being measured in a fluorimeter (Spectra 
Max M3, Molecular Devices, USA) equipped with a 400 nm excitation filter and a 
505 nm emission filter.  
 
Furthermore, qualitative analysis was performed by laser scanning microscopy. Calu-
3 cells were seeded at a density of 1x10
4
 cells/cm
2
 and treated with 0.2 mg/mL GNPs 
in 8-well chamber slides for 72 hours. Cells were fixed with -20 °C methanol for 10 
minutes and with -20°C acetone for 1 minute on microscope cover-slips. The cover-
slips were washed twice with PBS and then blocked with PBS containing 0.1% BSA 
for 10 minutes at room temperature in the dark. Samples were incubated with 
Cathepsin-B (ab58802, Abcam, UK) in PBS containing 1% bovine serum albumin 
(BSA) for 60 minutes, and were washed three times in PBS. Following this, samples 
were incubated with Fluorescein anti-rabbit (A10526, Invitrogen, Germany) as the 
secondary antibody at a 1:40 dilution in PBS containing 1% BSA for 30 minutes at 
room temperature.  Samples were subsequently washed three times in PBS. Samples 
were then stained for both the cytoskeleton (F-actin labelled with Texas Red® 
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Phalloidin (T7471)) and the nuclear region (labelled with 4',6-diamidino-2-
phenylindole dye (DAPI)). ProLong Gold Antifade reagent (Invitrogen, Germany) 
was added onto the cover-slips before they were carefully inverted onto glass 
microscope slides. After the incubation period, samples were washed twice and 
images obtained by laser scanning microscopy (Carl Zeiss 510, Germany at a 63x 
magnification) as previously described [27]. At least five independent fields of view 
from three individual samples were captured in order to provide a representative 
qualitative understanding of Cathepsin-B expression in Calu-3 epithelial cells 
following GNP exposure.  
 
Reactive oxygen species (ROS) production. The ability for each type of GNP to 
generate ROS was determined by the DCFH-DA assay. It is important to note that 
DCFH-DA diffuses through the cell membrane readily and is hydrolysed by 
intracellular esterases to non-fluorescent DCF deacetylated, which is then rapidly 
oxidised to highly fluorescent DCF in the presence of ROS. The DCF fluorescence 
intensity is proportional to the amount of ROS formed inside the cell [26]. Further to 
this, when assessing the cellular associated ROS generation, the mitochondrial 
distribution of the ROS formation was assessed via the concomitant use of the 
MitoTracker Red CMXRos dye.  
 
The ability for GNPs to elucidate ROS formation within cells was determined. 
Initially, Calu-3 cells were seeded at a density of 1x10
4
 and treated with 0.2 mg/mL 
GNPs in an eight well chamber slide for 72 hours at 37 °C, 5% CO2. Cells were 
loaded with the fluorescent indicator at a final concentration of 300 nM with 
MitoTracker Red CMXRos dye (Catalogue number: M-7512; excitation/emission: 
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579/599 nm, Invitrogen,) 10 mM DCFH-DA dye and 0.2 µg/mL DAPI for 30 minutes 
at 37 °C, 5% CO2 in the dark. After the incubation period, samples were washed twice 
and images obtained by laser scanning microscopy (Carl Zeiss 510, Germany at a 63x 
magnification) as previously described [32]. At least five independent fields of view 
from three individual samples were captured in order to provide a representative 
qualitative understanding of the ROS production in Calu-3 cells following GNP 
exposure. 
 
Apoptosis Immunostaining. Calu-3 cells were seeded at a density of 1x10
4
 cells/cm
2
 
and treated with 0.2 mg/mL GNPs in 8-well chamber slides for 72 hours. Cells were 
fixed with -20 °C methanol for 10 minutes and with −20 °C acetone for 1 minute on 
microscope cover-slips. The cover-slips were washed twice with PBS and then 
blocked with PBS containing 0.1% BSA for 10 minutes at room temperature in the 
dark. Samples were incubated with anti-Caspase-8 rabbit (IMG-5704, Imgenex, USA) 
in PBS containing 1% bovine serum albumin (BSA) for 60 minutes, and then washed 
three times in PBS. Following this, samples were incubated with Alexa 546 anti-
rabbit (A11035, Invitrogen, Germany) as the secondary antibody and a green 
phalloidin probe (A12379, Invitrogen, Germany) (to denote the cell F-actin-
cytoskeleton) at a 1:40 dilution in PBS containing 1% BSA for 30 minutes. Samples 
were subsequently washed three times in PBS. After staining the nuclear region with 
4',6-diamidino-2-phenylindole dye (DAPI), one drop of ProLong Gold Antifade 
reagent (Invitrogen, Germany) was added onto the cover-slips before they were 
carefully inverted onto glass microscope slides. Samples were then imaged by laser 
scanning microscopy (Carl Zeiss 510, Germany, at a 63x magnification). With each 
method, four images per sample were captured to gain a representative understanding 
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of the onset of apoptosis in Calu-3 epithelial cells following GNP exposure. 
Subsequently image analysis was performed (i.e. quantification of fluorescent 
density) with ImageJ (a Java-based software freely available at NIH, version 1.45s), 
according to the procedure described in [26].  
 
Fas-Receptor and Caspase protein expression. At 5×10
5
 Calu-3 cells were seeded 
in a 30 mm
2
 polystyrene dish and exposure with different concentrations of GNPs 
from 0.02, 0.1, 0.2, 0.5 and 1 mg/mL for 72 hours.  Protein extract of Calu-3 cells was 
boiled in sample buffer for 3 minutes and loaded onto 12% SDS-polyacrylamide gels. 
Details of the Western immunoblotting procedure are described in the previous work 
of Tian et al. [32]. Total protein of each sample was then quantified using a protein 
quantification reagent from Bio-Rad (Bio-Rad Protein Assay Dye Reagent (#500-
0006), Munich, Germany) and the same amount of protein was loaded onto the gel as 
described elsewhere [33].  The antibodies used for this experiment were as follows: 
rabbit anti-Fas (X-20, sc-1024 Santa Cruz Biotechnology, USA), rabbit anti- active 
Caspase-3 that recognizes the cleaved CASP3 fragment, AS 171-175 of P42574  
(D175, mAb clone 9H19L2, Catalog number 700182, Invitrogen, Germany), rabbit 
anti-active Caspase-9, that recognizes the cleaved CASP9 fragment adjacent to 
Asp353 (ab52298 Abcam, UK; 1:1000 dilution), and anti-rabbit IgG horseradish 
peroxidase (Amersham-Pharmacia Biotech, UK; 50000:1 dilution). The Western blot 
was visualised using a chemiluminescence kit (ECL, Amersham-Pharmacia Biotech) 
and Western blots were transferred to Bio-RAD Imaging, USA. A densitometric 
analysis was performed using ImageJ (version 1.45s) and protein expressions were 
normalised to the density of 1 mg/mL hexagonal GNPs respectively (100%) Analysis 
was performed in triplicates and from three independent experiments (n=3). 
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Statistical analysis. All data is presented as the mean ± standard deviation (SD). 
Significant differences between two groups were evaluated by a Student’s t-test, or 
between multiple groups via a two-way ANOVA. Regression analysis was performed, 
as well as Tukey’s multiple comparison post-hoc tests to identify the source of 
variance. Statistical analysis was performed using GraphPad Prism 5.0 (GraphPad 
Software, USA). The alpha value was set to 0.05. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
RESULTS 
 
GNP physico-chemical characteristics. The main physico-chemical properties of 
each shape, including diameter, volume, thickness, absorbance peak, surface 
modification and charge are listed in table 1. Briefly, TEM and SEM analysis 
revealed spherical GNPs to have an average diameter of 30 nm (Fig. 1A, A’). Both 
the triangular and hexagonal GNPs were found to be ~9 nm thick [8], with a 
respective average side length of triangles and longest diagonal for hexagon being 120 
nm and 150 nm (Fig. 1B, B’ and 1C, C’). All three GNP types were found to exhibit a 
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negative zeta potential in cell culture medium (-17.7 to -16.3 mV) (Table 1). Despite 
the same surface chemistry, the different GNPs exhibited an altering surface area 
(nm
2
) (2827.4 (spherical), 12470.4 (triangular), 38971.1 (hexagonal)) and volume 
(nm
3
) (14137 (spherical), 56118 (triangular), 131528 (hexagonal)) per GNP. 
 
Association of GNPs with Calu-3 cells. Following numerous washing steps, as well 
as trypsinization, all AAS analysis was based on the assumption that the measured 
quantity of gold can be considered as GNPs either internalised or tightly attach to the 
surface of cells. No significant difference was observed between the total mass of 
triangular and spherical GNPs measured per dish (Table 2). The total mass measured 
per dish for the hexagonal GNPs, however, exceeded both the spherical and triangular 
GNPs by a factor of two and five respectively (Table 2). Adjusting for the cell 
numbers per plate indicates that 0.22, 0.42 and 2.65 ng gold could be associated per 
cell for spherical, triangular and hexagonal GNPs. To further estimate the number of 
GNPs per cell, the number of GNPs per dish was estimated by the specific volume of 
each different shaped GNP (Table 2). From the calculated particle volume, it was 
subsequently possible to determine the number of GNPs per cell (also considering the 
cell density per dish) to be triangle<spherical<hexagonal. This finding was important 
in considering the role played by each GNP type in the subsequent biochemical 
effects observed (p<0.01) (Table 2). Considering further the size of the different 
GNPs, the respective volumes occupied by this GNP number per cell of spherical, 
triangle and hexagonal GNPs proved to be 1:2:11 (in detail: 1.1 x10
5
, 2.0 x10
5
 and 
1.2E x10
6
 nm
3
/cell). 
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Sub-cellular distribution of GNPs. After 72 hours suspension exposure to 0.1 
mg/mL, spherical GNPs were found to be both freely-distributed in the cytoplasm, as 
well as located in membrane-bound compartments of Calu-3 cells (Fig. 2). The image 
in Fig. 2A’ shows a vesicle, confirmed via distinctively contrast stained membrane 
contours, containing spherical GNPs. Similar findings were also observed for the 
triangular GNPs (Fig. 2B). The varying intracellular localisation of the two different 
shaped GNPs could suggest a number of different uptake routes occurring 
simultaneously by the Calu-3 cells, or that the GNPs are able to escape from the 
vesicles, during the intracellular trafficking cascade, into the cytosol. However, at this 
sample point, hexagonal GNPs were only found to be present within membrane-
bound compartments inside Calu-3 cells (Fig. 2C). It is also noticeable that triangular 
shaped GNPs are within this vesicle (Fig. 2C). This is due to the fraction (10%) of 
triangular GNPs from the shape separation technique used for the hexagonal GNPs. 
 
Shape-dependent impact on cell viability and cytotoxicity. Triangular GNPs 
exhibited a reduced survival rate compared to spherical GNPs after 72 hours 
following exposure up to 1 mg/mL (91% triangular vs. 99% spherical). Despite these 
differences, no significant (p>0.05) changes in cell viability were observed for either 
GNP type compared to the negative control at all concentrations tested (Fig. 3A). In 
contrast, a significant (p<0.05) loss, compared to negative control levels, in Calu-3 
cell viability was found following exposure to hexagonal GNPs (57% viable) for 72 
hours at 1 mg/mL (Fig. 3A). Noticeably, Calu-3 cells remained viable for all GNP 
shapes and concentrations up to 0.1 mg/mL after 72 hours (Fig. 3A). Further to the 
findings at 1 mg/mL, the loss in cell viability observed after hexagonal GNP exposure 
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was found to be significantly different (p<0.01) to the status of the Calu-3 cells after 
exposure to both spherical and triangular GNPs (Fig. 3A).   
 
No significant (p>0.05) LDH release was observed for either the spherical or 
triangular GNPs after exposure for 72 hours up to a test concentration of 1 mg/mL 
(Fig. 3B). At the same particle concentration, hexagonal GNPs showed a significant 
(p<0.05) LDH release, exceeding 10% over control levels, as well as to both the 
spherical and triangular GNP at all concentrations tested (Fig. 3B).  
 
Cathepsin-B expression. Spherical and triangular shaped GNPs showed limited 
changes to the presumed punctuated lysosomal Cathepsin-B expression compared to 
the negative control, as determined via laser scanning microscopy (Fig. 4A-C). 
Treatment with hexagonal GNPs caused a significant alteration to cell morphology, 
with deformed and disintegrated F-actin cytoskeleton indicating the progression of 
apoptotic degeneration (Fig. 4C), as compared with the negative control (Fig. 4A). 
Strong Cathepsin-B protein expression, evident by bright fluorescence signals in 
perinuclear granules, was also observed for hexagonal but not spherical or triangular 
GNP treated cells (Fig. 4D). In support of the microscopy approach, subsequent 
quantitative analysis of Cathepsin-B activity showed that the protease activity in cell 
extracts of hexagonal-treated cells exceeds that of the negative control and triangular 
GNPs in a concentration-dependent manner (p<0.001) (Fig. 4E).  
 
ROS production. In cells dosed with 0.2 mg/mL hexagonal GNPs a strong DCFH-
DA derived DCF-fluorescence signal indicated substantial ROS activity in the vicinity 
of the MitoTracker (TMRM) signal, a mitochondrial membrane potential sensitive 
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dye (Fig. 5C, D). No sign for ROS formation was observed for triangular (Fig. 5A, B) 
as well as spherical particles (not shown). The overall diffuse DCF signal and the 
weak overlap with the localization of the TMRM fluorescence indicates that the 
hexagonal GNPs caused intracellular ROS formation is not significantly associated to 
the mitochondria, and therefore might not be caused by mitochondrial destabilization.  
 
Shape-dependent stimulation of CD95 (APO-1/Fas) receptor and Caspases. No 
Caspase-8 expression was found in Calu-3 cells treated with spherical (data not 
shown) or triangular shaped GNPs (Fig. 6B). In contrast a strong cytoplasmatic 
expression was detected in cells following exposure to hexagonal GNPs after 72 hours 
at 0.2 mg/mL (Fig. 6D). Since Caspase-8 is an initiator Caspase activated by the 
extrinsic death receptor pathway, such as the Fas receptor (CD95), which in turn 
activates effector caspases like caspase 3 either directly or via the mitochondria 
mediated Caspase-9 apoptosome,  the expression of Caspase-3 and -9, as well as Fas 
in Calu-3 cells were further investigated by immunoblotting. Expression of Fas, 
activated Caspase-3 (19kDa form) and activated Caspase-9 (21 kDa form) was 
significantly higher for the hexagonal GNPs at 0.2, 0.5 and 1 mg/mL compared to 
both triangular and spherical GNPs (Fig. 7). The dose response for Fas and Caspases-
3 expression levels showed a sigmoidal curve suggesting the onset of apoptosis in 
Calu-3 epithelial cells requires a minimal dose of 0.1 - mg/mL of hexagonal GNPs 
for 72 hours (Fig. 7). Importantly, no significant expression changes (p>0.05) were 
observed for spherical and triangular GNPs, neither for the Fas death receptor nor for 
the activation indicating caspase forms at any of the concentrations studied (Fig. 7). 
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DISCUSSION 
It is widely accepted that both geometric properties and surface design can 
significantly alter the interaction of NPs with cells, cellular membranes, as well as 
influence their intracellular localisation and distribution. Nonetheless, prediction of 
biocompatibility based on NP shape and dimensions is extremely challenging [34-36]. 
Despite this, novel NPs are constantly being created in a wide range of shapes (e.g. 
hexagons, triangles, urchins, roses, needles) [8,13]. Currently though, it is unclear 
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how the specific tuning of NP shape can be achieved in order to serve as precise 
(biomedical) tools whilst eliciting limited impact upon cellular homeostasis. The aim 
of the present study therefore, was to study a panel of three differently shaped GNPs 
with identical surface chemistry and determine their impact upon the biocompatibility 
to the airway epithelia using the Calu-3 cell-line as a model. 
 
In summary, the shape-related GNP biocompatibility investigated within the current 
study followed the sequence of spherical>triangular>>hexagonal. The findings of the 
present study clearly show that both spherical and triangular GNPs, in contrast to 
hexagonal GNPs, elicited only limited, if not negligible cytotoxicity, whilst hexagonal 
GNPs, at least at doses exceeding 0.1 mg/mL, significantly affected cell viability. It is 
important to note however, that the concentration (1 mg/mL) causing a severe 
cytotoxic effect upon Calu-3 cells following hexagonal GNP exposure may be 
considered as a factitious high dose situation [37]. This is evident as shown in figure 
3A where the viability of the Calu-3 epithelial cells treated with more than 0.1mg/mL 
of hexagonal GNPs is dropping to 80% compared to controls, while spherical and 
triangular GNPs show no effect, indicating doses over 0.1 mg/mL represent a 
cytotoxic concentration. Also at doses from 0.2 mg/mL, for hexagonal GNPs, the F-
actin cytoskeleton was found deformed, caspases activity (indicates the strong 
activation of both intrinsic and extrinsic apoptotic pathways) increased and the 
expression of lysosomal enzyme Cathepsin-B heightened. The onset of apoptotic cell 
death within Calu-3 epithelial cells over the 72 hour exposure period to hexagonal 
GNPs can further be associated with the significant increase in non-mitochondrial 
ROS production since the induction of cell death can be elucidated by an increase in 
ROS, and are in support of the findings of a recent study by Hutter et al. [6]. 
22 
 
Furthermore, these findings support previous research that has shown spherical, 
isotropic GNPs larger than 5 nm to cause limited influence upon cell viability [38], 
while less is known for anisotropic GNPs such as triangular or hexagonal shapes [39].  
 
When focussing on these findings it might be considered surprising that at an equal 
applied mass dose, sharp angular shaped triangular gold platelets are less cytotoxic 
than hexagonal objects of comparison. In this context, a related study identified 
triangular silver nanoplates to be more toxic to hepatocellular carcinoma cells than 
silver nanospheres[40]. However in the present study, the biocompatibility of the 
known reactive vertices of the triangular GNPs revealed to be indistinguishable from 
spherical GNPs[8]. It is possible, in this regard, that the adverse biological impact 
noted may be influenced by a multitude of factors such as, aspect ratio, particle size 
and particle surface area [41,42]. Although such an effect could also suggest that a 
threshold exists as regards the specific surface geometry (i.e. number of ‘vertices’) of 
GNPs and their resultant biological impact. For example, when based upon the 
cytotoxicity data presented in the currently manuscript, it could be hypothesised that 
the heightened number of vertices are directly related to the increase in cell membrane 
damage (LDH release). This hypothesis can be attributed to the fact that NPs with an 
increased number of vertices can elicit a heightened (surface) reactivity which, when 
considered in regards to their interaction with cellular membranes could elicit a 
negative biological impact[40]. Further research is necessary however, to associate 
this hypothesis with the vertices of the hexagonal GNPs used in this study.  
 
Nonetheless, why hexagonally-shaped GNPs elicit a decrease in epithelial cell 
viability is not abundantly apparent, despite the clear differences in biochemical 
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response between the three GNP shapes. Thus, a number of additional hypotheses can 
also be considered. One possibility is that the individual hexagonal GNPs are heavier 
than the triangular GNPs. Furthermore, since the hexagonal GNPs encompass a 
greater number of vertices (6) than the triangular (3), the number of protein binding 
sites is increased; proposing a greater possibility of a potential immunomodulatory 
impact upon cells. If however, as suggested above, geometry was considered a 
secondary issue for cytotoxicity, and the NP-cell interaction was analysed in terms of 
NP mass, as well as number and volume, a different picture arises. This approach has 
most notably been observed by Ferin et al., in one of the first studies to report the 
biological impact of nano-sized materials, [43]. Even though the numbers of GNPs  
‘associated’ with the cells seem comparable for spherical, triangular and hexagonal 
GNPs and differ only by about two fold (2.3 / 1 / 2.7), the ratio of the corresponding 
GNP mass matches well with their previously described order of toxicity. 
Accordingly, the cell associated hexagonal GNP mass occupied a 12 times higher 
volume as compared to spherical, and a six times higher volume as compared to 
triangular GNPs. A similar estimate of course applies for the respective particle 
surface area, which has been established as the most appropriate dose-metric for 
comparing the effects of NPs of different sizes[37,44,45].  In this regard, the sub-
cellular deposition of GNPs shows some interesting differences between the shapes. It 
is known that GNPs are often confined to endosomes and similar compartments when 
cells undergo endocytosis [46]. As further denoted in table 2, there were 8.06E
+5
 
spherical GNPs and 5E
+5
 triangular GNPs per and 9.4E
+5
 hexagonal GNPs per cell 
after 72h exposure. Hexagonal GNPs were only found to be located in vesicles, while 
spherical GNPs and triangular GNPs were found both inside and outside of 
membrane-bound compartments inside Calu-3 epithelial cells; a possible reasoning 
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behind the increased Cathepsin B expression following exposure to the hexagonal 
GNPs. Thus, the mode of interaction (i.e. cellular uptake mechanism) could play a 
pivotal role in how the cells internalise the GNPs and therefore contributing to the 
biocompatibility of GNPs.  
 
In addition to the specific uptake mechanisms at play, the precise physical manner in 
which different shaped nanomaterials interact (or associate) with cells has been of 
increased interest recently. Most notably, the concept of ‘angle of attack’ has been 
considered [47]. In this regard, it is conceived that the NPs interact with the cell 
surface and the total parallel component of the kinetic energy produced contributes to 
a cutting wear [48]. Therefore, due to the small, flat surface of the hexagonal GNPs, it 
can be assumed that the hexagonal GNPs could engage in a small angle of attack 
resulting in a greater mass internalisation of hexagonal GNPs within the Calu-3 cells 
compared to the spherical and triangular GNPs (0.53±0.05 mg vs. 0.11±0.04 mg 
(spheres) and 0.19±0.08 mg (triangular)). However, such assumptions are based upon 
modelling, or upon larger particle sizes. Alternatively however, strong consideration 
for the physical parameters acting upon the cellular interaction of the different shaped 
GNPs should be given towards the increased mass internalised by the Calu-3 cells, 
and the potential for a heightened sedimentation rate of the heavier hexagons 
compared to both the spheres and triangles[49]. Although further research is 
necessary to deduce between these aspects, the difference in total mass of GNPs per 
cell) is subsequently postulated as contributing to the differences in the biochemical 
responses observed between the different GNP shapes when considered with their 
surface area. As, although hexagonal GNPs show a three times greater internalised 
mass per cell compared to the triangular GNPs, they are similar to that of the spherical 
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GNPs. However, since the internalized particle surface area of hexagonal GNPs 
exceeds that of the spheres and triangles by a factor of 10, this increase in the cell 
associated particle dose likely explains the observed increases in cellular stress and 
cytotoxicity. Thus it is strongly advised that NP biocompatibility and toxicological 
studies, in addition to the ‘administered mass’, consider the ‘cell delivered’ dose 
metric, as this is suggested as being highly relevant for insoluble materials. 
 
 
 
 
 
 
 
 
 
 
 
 
CONCLUSION 
In conclusion, it is not only the geometry of GNPs directly driving their 
biocompatibility with Calu-3 epithelial cells, but when exposed at the same mass 
dose, the intracellular number, mass and volume of GNPs resultant of their specific 
interaction and internalisation that contributes towards the observed adverse cellular 
response. Therefore, it is these, combined characteristics that are crucial determinants 
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that require particular consideration in the development of safe, biocompatible 
nanomaterials for biomedical applications.  
 
 
 
 
 
 
 
 
 
 
 
 
SUMMARY POINTS 
 The present study shows, via a systematic study, the impact of Au NP 
geometry upon lung cell homeostasis in vitro.  
 At sub-lethal concentrations, the adverse biological impact (increase of 
reactive oxygen species, apopototic pathways and lysosomal burst) of 
alternative Au NP geometry showed hexagons>triangles>spheres. 
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 The impact of differently shaped Au NPs is not specific to the NP shape, 
however is due to a convoluted paradigm combining the physico-chemical 
characteristics of surface area, volume and mass. Together with NP 
concentration and number, these variables were all considered to significantly 
influence the interaction of Au NPs with altered geometry with lung epithelial 
cells in vitro. A use of the ‘delivered to cell’ dose metric might be 
toxicologically more relevant than the ‘administered mass’ itself. 
 Au NPs varying in their geometry must be individually considered for their 
hazard potential prior to their proposed advantageous use within nanomedical 
applications.  
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Figure 1. Morphology of the different shaped GNPs. Images show the morphological 
aspects of (A, A’) spherical, (B, B’) triangular and (C, C’) hexagonal shaped GNPs as 
used in the present study. (A-C) show Transmission electron microscopy images. (A’-
C’) show scanning electron microscopy images. Scale bar represents 150 nm. Please 
refer to table 1 for the key physico-chemical characteristics of all three different GNP 
shapes. 
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Figure 2. Transmission electron microscopy images of the sub-cellular localisation of 
the different shaped gold nanoparticles (GNPs) in Calu-3 epithelial cells after 72 
hours exposure at [1 mg/mL] under suspension culture conditions (37°C, 5% CO2). In 
image (A), spherical GNPs are shown to be free within the cytoplasm of the cells, 
whilst (A’) shows spherical GNPs to be localised within a membrane-bound 
compartment. (B) Triangular GNPs were found to reside with a membrane bound 
compartments, as further highlighted by the magnified image (B’). Image B also 
shows the triangular GNPs to be free within the cytoplasm of the cell at this time. 
Images C and C’ indicate that the intracellular localisation of the hexagonal GNPs is 
within vesicular compartments of the Calu-3 cells. For each replication (n=3), a total 
of 5 fields of interest were observed in order to capture a representative image of each 
shaped GNP-cell interaction. Scale bar equals 150nm.  
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Figure 3. Shape-dependent cytotoxicity upon Calu-3 epithelial cells. (A) Shows the 
percentage of cell viability (WST-1 assay) and (B) the cytotoxicity indicated by 
lactate dehydrogenase (LDH) release after 72 hours exposure to GNPs. Cell viability 
(WST-1) and membrane permeability (LDH release) were analysed with 
concentrations ranging from [0.00001 to 1 mg/mL] for 72 hours under suspension 
culture conditions (37°C, 5% CO2). The effect of the GNPs on cell viability had the 
following sequence: spheres>triangular>>hexagonal GNPs (** p< 0.01 compared to 
hexagonal groups). A similar sequence was also noted for the ability for GNPs to 
cause cell membrane disruption related to LDH release (# p<0.05; compared to 
spherical groups, + p<0.05; compared to and triangular groups). The LDH percentage 
has been normalized against the positive control (0.2% Triton X100). Data shown is 
the mean ± standard error of the mean (SEM) (n=3).  
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Figure 4. Cathepsin-B expression in Calu-3 epithelial cells. Laser scanning 
microscopy images show Calu-3 cells treated with (A) cell culture medium only, (B) 
spherical GNPs, (C) triangular GNPs and (D) hexagonal GNPs at [0.2 mg/mL] for 72 
hours under suspension culture conditions (37°C, 5% CO2). The observed punctuated 
Cathepsin-B expression (green) evident in D indicates lysosomal localization. Limited 
expression is seen in both B and C, although not different to that noted in A, the 
negative control (cell culture medium only). The F-actin of the cell cytoskeleton 
(Texas Red® Phalloidin; red) and nuclei (DAPI stain; blue) were labelled to provide 
an indication of cell structure and status. The actin-cytoskeleton was noted to be 
significantly deformed following hexagonal GNP exposure compared to both 
spherical and triangular GNPs. (E) represents a quantified increase in Cathepsin-B 
activity in Calu-3 cells exposed for 72 hours to triangular and hexagonal GNPs at 
concentrations ranging from [0.01-1 mg/mL].Activity levels are shown as fold 
changes relative to the control. Scale bars represent 10 µm. Images are representative 
of three independent experiments. 
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Figure 5. Reactive oxygen species (ROS) formation in Calu-3 epithelial cells. ROS 
formation (green) was assessed by the DCFH-DA assay and analysed for its 
association with the active mitochondria of the Calu-3 cells by using the fluorescent 
organelle marker ‘Mitotracker’ (red). Calu-3 cells were exposure for 72 hours to 
triangular (A, B) and hexagonal (C, D) GNPs at [0.2 mg/mL] under suspension 
culture conditions (37°C, 5% CO2). Cell nuclei (DAPI stain; blue) were also labelled 
to provide an indication of the structure and status of the cell. All images show 
merged channels for ROS formation and cellular mitochondria. Laser scanning 
microscopy images indicate that triangular GNPs caused limited ROS production 
under the experimental conditions tested. However, the hexagonal GNPs elicited an 
abundant increase in ROS formation over 72 hours at [0.2 mg/mL], although this was 
not found to be associated within the mitochondria. Following both GNPs exposures, 
the no changes were evident towards the mitochondria of the Calu-3 cells. Scale bars 
represent 10 µm. Images are representative of three independent experiments. 
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Figure 6. Caspase-8 expression in Calu-3 epithelial cells. Laser scanning microscopy 
images show Calu-3 cells treated with (A, B) triangular GNPs and (C, D) hexagonal 
GNPs for 72 hours at [0.2 mg/ml] under suspension culture conditions (37°C, 5% 
CO2). Images (B) and (D) show merged images of Caspase-8 (red) and F-actin 
(Phalloidin; green) staining, with the cell nuclei in blue (DAPI; blue). After treatment 
with hexagonal GNPs the integrity of the cytoskeleton of the Calu-3 cells was found 
to alter compared to treatment with triangular GNPs. Following treatment with 
hexagonal GNPs however, a clear increase in Caspase-8 production was noted 
compared to the epithelial cells treated with triangular GNPs. Scale bars represent 10 
µm. Images are representative of three independent experiments. 
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Figure 7. Shape-dependent expression of apoptosis-related proteins (Fas, Caspase-3 
and Caspase-9) in Calu-3 epithelial cells after treatment to alternative shaped GNPs 
for 72 hours under suspension culture conditions (37°C, 5% CO2). (A) arrow points 
last column of Western blot anlaysis for Fas (~50 kDa), Caspase-3 (cleaved 19kDa 
form) and Caspase-9 (cleaved 21 kDa form) showing different protein expressions 
after Calu-3 cells were exposed to [1 mg/mL] of spherical, triangular or hexagonal 
shaped GNPs. (B) shows different protein expression in cells exposed to  hexagonal 
GNPs at [0.02, 0.1, 0.2, 0.5 and 1mg/mL]. Graphs C-E show the relative percentages 
of Fas death receptor, effector Caspase-3 and initiator Caspase-9 following Calu-3 
cell treatment with [1 mg/ml] GNPs (■ hexagonal shaped GNPs, ▲ triangular shaped 
GNPs, ○ spherical shaped GNPs) (n=3). 
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Table 1. Key physicochemical characteristics of the different shaped GNPs used. 
Sample 
Diameter 
(nm) 
Thickness 
(nm) 
Surface 
Area per 
GNP(nm
2
) 
Volume 
per 
GNP 
(nm
3
) 
Surface 
modification 
max 
(nm) 
Zeta 
potential 
in cell 
culture 
medium 
(mV) 
Spherical 30  2827.4 14137 
HS-PEG-
COOH 
528 
-
17.3±1.2 
Triangular 120 9 12470.4 56118 
HS-PEG-
COOH 
900 
-
17.7±1.9 
Hexagonal 150 9 38971.1 131528 
HS-PEG-
COOH 
1100 
-
16.3±1.1 
 
 
Table 2. Quantification of cell associated GNPs as calculated by Atomic Absorption 
Spectroscopy (AAS) in Calu-3 cells after 72 hours exposure at 1 mg/mL. 
GNP 
Shape 
Total Au mass 
per dish (mg) 
Total Au 
volume per 
dish (m
3
) 
GNP 
volume (m
3
) 
GNPs per 
dish 
Cells 
per 
dish† 
Estimated 
GNPs per 
cell 
GNP 
mass 
per 
cell 
(ng) 
   
Sphere 0.11±0.04 
5.69±2.07 
X10
-12
 
1.41±0.51 
X10
-23
 
4.03±1.47 
X10
11
 
5±1.82 
X10
5
 
8.06±2.93 
X10
5
  
0.22    
Triangle 0.19±0.08 
9.84±4.14 
X10
-12
 
6.24±2.62 
X10
-23
 
1.58±0.66 
X10
11
 
4.5±1.9 
X10
5
 
3.51±1.47 
X10
5
 
0.42    
Hexagon 0.53±0.05* 
2.74±0.26 
X10
-11
 
1.46±0.13 
X10
-22
 
1.88±1.77 
X10
11
 
2±0.19 
X10
5
  
9.40±0.89 
X10
5
  
2.65    
 
*p<0.01;  Au density = 1.93E+07 g/m
3 
† The different cell number per dish reported is related to the cytotoxicity observed following 
Calu-3 exposures.  
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